Subscribe to Newsletter

Business & Regulation

Business & Regulation Supply Chain

Weight Loss Fakers

| Stephanie Vine

Researchers purchase Ozempic online and test for authenticity. Yes, it was counterfeit.

Business & Regulation Profession

Video Interview: Debra Weiss

Check out our video interview with Debra Weiss from the Bill & Melinda Gates Medical Research Institute.

Business & Regulation Profession

Sitting Down With… The Past: Anne Phelan

| 2 min read

We dive into the archive of 2020 for insight and inspiration – this time with Anne Phelan.

Business & Regulation Standards & Regulation

EMA: No to Lecanemab

| Stephanie Vine | 3 min read

Lecanemab is refused marketing authorization by the European Medicines Agency.

Business & Regulation Standards & Regulation

The Choice: To Be Cured or to Have Children?

| Stephanie Vine

Fertility support programs for gene therapy Medicare patients are being blocked in the US.

Business & Regulation Standards & Regulation

Starting with the End in Mind

| Drew Hope | 7 min read

Collaboration and thoughtful automation at scale will be critical for unlocking cell and gene therapies for patients

Business & Regulation Trends & Forecasts

Dystopia or Utopia? Contribute to our Special Feature on the Future of Pharma

| Stephanie Vine | 4 min read

Contribute to our special feature celebrating the future of pharma.

Business & Regulation Digital Technologies

Industry 4.0 in Action

| Balajikasiram Sundararajan | 6 min read

A company shares their experience with Industry 4.0 – including the types of digital technologies implemented and the benefits being seen.

Business & Regulation Profession

Sitting Down With… The Past: Bruce Levine

| 2 min read

We dive into the archive of 2019 for insight and inspiration – this time with Bruce Levine.

Business & Regulation Supply Chain

Political Change Around China Means Change for Pharma

| Kerry Pickstone | 4 min read

Why companies must tighten their supply chains in light of Chinese anti-espionage laws and other regulatory clampdowns.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register